These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 30504712
1. Patients with Atrial Fibrillation and Chronic Kidney Disease More Often Undergo Angioplasty of Left Main Coronary Artery - a 867 Patient Study. Tomaszuk-Kazberuk A, Nikas D, Lopatowska P, Młodawska E, Malyszko J, Bachorzewska-Gajewska H, Dobrzycki S, Sobkowicz B, Goudevenos I. Kidney Blood Press Res; 2018; 43(6):1796-1805. PubMed ID: 30504712 [Abstract] [Full Text] [Related]
2. Is there association between changes in eGFR value and the risk of permanent type of atrial fibrillation? Analysis of valvular and non-valvular atrial fibrillation population. Mlodawska E, Tomaszuk-Kazberuk A, Lopatowska P, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S, Musial WJ. Kidney Blood Press Res; 2014; 39(6):600-8. PubMed ID: 25531163 [Abstract] [Full Text] [Related]
3. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease. Tajti P, Karatasakis A, Danek BA, Alaswad K, Karmpaliotis D, Jaffer FA, Choi JW, Yeh RW, Patel M, Mahmud E, Burke MN, Krestyaninov O, Khelimskii D, Toma C, Doing AH, Uretsky B, Koutouzis M, Tsiafoutis I, Wyman RM, Garcia S, Holper E, Xenogiannis I, Rangan BV, Banerjee S, Ungi I, Brilakis ES. J Invasive Cardiol; 2018 Nov; 30(11):E113-E121. PubMed ID: 30218557 [Abstract] [Full Text] [Related]
4. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014. Ismail MD, Jalalonmuhali M, Azhari Z, Mariapun J, Lee ZV, Zainal Abidin I, Wan Ahmad WA, Zuhdi ASM, NCVD-PCI investigators. BMC Cardiovasc Disord; 2018 Sep 24; 18(1):184. PubMed ID: 30249197 [Abstract] [Full Text] [Related]
5. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Parikh PB, Jeremias A, Naidu SS, Brener SJ, Lima F, Shlofmitz RA, Pappas T, Marzo KP, Gruberg L. Catheter Cardiovasc Interv; 2012 Sep 01; 80(3):352-7. PubMed ID: 22566286 [Abstract] [Full Text] [Related]
6. Chronic kidney disease predicts atrial fibrillation in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention. Șerban RC, Șuș I, Lakatos EK, Demjen Z, Ceamburu A, Fișcă PC, Somkereki C, Hadadi L, Scridon A. Acta Cardiol; 2019 Dec 01; 74(6):472-479. PubMed ID: 30650039 [Abstract] [Full Text] [Related]
7. Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. Hawkins NM, Jhund PS, Pozzi A, O'Meara E, Solomon SD, Granger CB, Yusuf S, Pfeffer MA, Swedberg K, Petrie MC, Virani S, McMurray JJ. Eur J Heart Fail; 2016 Sep 01; 18(9):1162-71. PubMed ID: 27594177 [Abstract] [Full Text] [Related]
8. Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. Corrao S, Argano C, Nobili A, Marcucci M, Djade CD, Tettamanti M, Pasina L, Franchi C, Marengoni A, Salerno F, Violi F, Mannucci PM, Perticone F, REPOSI Investigators. Eur J Intern Med; 2015 May 01; 26(4):243-9. PubMed ID: 25749554 [Abstract] [Full Text] [Related]
9. The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project. Yang L, Ye N, Wang G, Bian W, Xu F, Zhao D, Liu J, Hao Y, Liu J, Yang N, Cheng H, CCC-ACS. BMC Cardiovasc Disord; 2021 Jul 17; 21(1):345. PubMed ID: 34273963 [Abstract] [Full Text] [Related]
10. Different types of atrial fibrillation, renal function, and mortality in elderly Chinese patients with coronary artery disease. Fu S, Liu T, Luo L, Ye P. Clin Interv Aging; 2014 Jul 17; 9():301-8. PubMed ID: 24600210 [Abstract] [Full Text] [Related]
11. Improvement in estimated glomerular filtration rate in patients with chronic kidney disease undergoing catheter ablation for atrial fibrillation. Navaravong L, Barakat M, Burgon N, Mahnkopf C, Koopmann M, Ranjan R, Kholmovski E, Marrouche N, Akoum N. J Cardiovasc Electrophysiol; 2015 Jan 17; 26(1):21-7. PubMed ID: 25142836 [Abstract] [Full Text] [Related]
12. Outcome after coronary artery bypass surgery and percutaneous coronary intervention in patients with atrial fibrillation and oral anticoagulation. Gunn J, Kuttila K, Kiviniemi T, Ylitalo A, Biancari F, Juvonen T, Airaksinen KE. Ann Med; 2014 Aug 17; 46(5):330-4. PubMed ID: 24813457 [Abstract] [Full Text] [Related]
13. Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study. Verdoia M, Barbieri L, Schaffer A, Bellomo G, Marino P, De Luca G, Novara Atherosclerosis Study (NAS) group. Thromb Res; 2016 May 17; 141():139-44. PubMed ID: 27039166 [Abstract] [Full Text] [Related]
14. Improvement of HAS-BLED bleeding score predictive capability by changing the definition of renal dysfunction in Japanese atrial fibrillation patients on anticoagulation therapy. Suzuki M, Matsue Y, Nakamura R, Matsumura A, Hashimoto Y. J Cardiol; 2014 Dec 17; 64(6):482-7. PubMed ID: 24836929 [Abstract] [Full Text] [Related]
15. The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts renal function decline over time in elderly patients with atrial fibrillation and chronic kidney disease. Beyer-Westendorf J, Kreutz R, Posch F, Ay C. Int J Cardiol; 2018 Feb 15; 253():71-77. PubMed ID: 29306476 [Abstract] [Full Text] [Related]
16. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. Horio T, Iwashima Y, Kamide K, Tokudome T, Yoshihara F, Nakamura S, Kawano Y. J Hypertens; 2010 Aug 15; 28(8):1738-44. PubMed ID: 20485194 [Abstract] [Full Text] [Related]
17. Management of Adults with Newly Diagnosed Atrial Fibrillation with and without CKD. Bansal N, Zelnick LR, Reynolds K, Harrison TN, Lee MS, Singer DE, Sung SH, Fan D, Go AS. J Am Soc Nephrol; 2022 Feb 15; 33(2):442-453. PubMed ID: 34921110 [Abstract] [Full Text] [Related]
18. Warfarin, kidney dysfunction, and outcomes following acute myocardial infarction in patients with atrial fibrillation. Carrero JJ, Evans M, Szummer K, Spaak J, Lindhagen L, Edfors R, Stenvinkel P, Jacobson SH, Jernberg T. JAMA; 2014 Mar 05; 311(9):919-28. PubMed ID: 24595776 [Abstract] [Full Text] [Related]
19. Influence of renal function on anticoagulation control in patients with non-valvular atrial fibrillation taking vitamin K antagonists. Lobos-Bejarano JM, Castellanos Rodríguez A, Barrios V, Escobar C, Polo-García J, Del Castillo-Rodríguez JC, Vargas-Ortega D, Lopez-Pineda A, Prieto-Valiente L, Lip GYH, PAULA Study Team. Int J Clin Pract; 2017 Sep 05; 71(9):. PubMed ID: 28722795 [Abstract] [Full Text] [Related]
20. Outcomes of Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention Analysis of National Inpatient Sample. Shanmugasundaram M, Dhakal BP, Murugapandian S, Hashemzadeh M, Paul T, Movahed MR. Cardiovasc Revasc Med; 2020 Jan 05; 21(1):14-19. PubMed ID: 30971334 [Abstract] [Full Text] [Related] Page: [Next] [New Search]